# A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis

> **NCT02267642** · PHASE2 · COMPLETED · sponsor: **AbGenomics B.V Taiwan Branch** · enrollment: 20 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **BIOLOGICAL:** AbGn-168H

## Key facts

- **NCT ID:** NCT02267642
- **Lead sponsor:** AbGenomics B.V Taiwan Branch
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-10
- **Final completion:** 2016-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02267642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02267642, "A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02267642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*